⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SNY News
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma
globenewswire.com
SNY
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB
Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations
businesswire.com
GNE
SNY
QuantHealth Bolsters Executive Leadership Team to Support Its Expanding Product Portfolio and Growing Client Footprint
businesswire.com
IBM
SNY
Bavarian Nordic A/S – Notice Convening Annual General Meeting
globenewswire.com
JNJ
UCB
GSK
SNY
VICR
IOBT
FLS
IQV
Press release: Availability of the Q1 2026 aide-mémoire
globenewswire.com
SNY
Dupixent® (dupilumab) Approved in Japan as the First Targeted Medicine to Treat Adults with Bullous Pemphigoid (BP)
globenewswire.com
SNY
REGN
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
globenewswire.com
REGN
SNY
Damora Therapeutics Appoints Biotechnology Leader Jennifer Jarrett as President and Chief Executive Officer; Adds Two Industry Veterans to Board of Directors
globenewswire.com
DMRA
RCUS
UBER
PFE
SNY
ALGT
IPHA
GMED
Kali Therapeutics Announces Worldwide Exclusive License Agreement with Sanofi for Next-Generation Tri-Specific T-Cell Engager for Autoimmune Diseases
prnewswire.com
SNY